111 related articles for article (PubMed ID: 2705527)
1. Effect of chelators on copper metabolism and copper pools in mouse hepatocytes.
McArdle HJ; Gross SM; Creaser I; Sargeson AM; Danks DM
Am J Physiol; 1989 Apr; 256(4 Pt 1):G667-72. PubMed ID: 2705527
[TBL] [Abstract][Full Text] [Related]
2. Characterization of intracellular copper pools in rat hepatocytes using the chelator diamsar.
Bingham MJ; Sargeson AM; McArdle HJ
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1400-7. PubMed ID: 9227475
[TBL] [Abstract][Full Text] [Related]
3. Effects of cellular copper content on copper uptake and metallothionein and ceruloplasmin mRNA levels in mouse hepatocytes.
McArdle HJ; Mercer JF; Sargeson AM; Danks DM
J Nutr; 1990 Nov; 120(11):1370-5. PubMed ID: 2231026
[TBL] [Abstract][Full Text] [Related]
4. PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.
Nomura S; Nozaki S; Hamazaki T; Takeda T; Ninomiya E; Kudo S; Hayashinaka E; Wada Y; Hiroki T; Fujisawa C; Kodama H; Shintaku H; Watanabe Y
J Nucl Med; 2014 May; 55(5):845-51. PubMed ID: 24627433
[TBL] [Abstract][Full Text] [Related]
5. The effect of D-penicillamine on metallothionein mRNA levels and copper distribution in mouse hepatocytes.
McArdle HJ; Kyriakou P; Grimes A; Mercer JF; Danks DM
Chem Biol Interact; 1990; 75(3):315-24. PubMed ID: 2379260
[TBL] [Abstract][Full Text] [Related]
6. Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide.
Huang CW; Li Z; Cai H; Shahinian T; Conti PS
Bioconjug Chem; 2011 Feb; 22(2):256-63. PubMed ID: 21244039
[TBL] [Abstract][Full Text] [Related]
7. The effect of tetrathiomolybdate on the metabolism of copper by hepatocytes and fibroblasts.
McArdle HJ; Gross SM; Vogel HM; Ackland ML; Danks DM
Biol Trace Elem Res; 1989 Nov; 22(2):179-88. PubMed ID: 2484238
[TBL] [Abstract][Full Text] [Related]
8. [Urinary copper excretion from rats following administration of aliphatic and alicyclic polyamines (author's transl)].
Harders H; Armah B; Cohnen E; Führ J; Heinz N; Schröder HF
Arzneimittelforschung; 1980; 30(2):254-8. PubMed ID: 7378100
[TBL] [Abstract][Full Text] [Related]
9. Effect of thiol chelators on trace metal levels.
Tandon SK; Behari JR; Ashquin M
Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):501-4. PubMed ID: 6320321
[TBL] [Abstract][Full Text] [Related]
10. Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Delangle P; Mintz E
Dalton Trans; 2012 Jun; 41(21):6359-70. PubMed ID: 22327203
[TBL] [Abstract][Full Text] [Related]
11. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
Baker E; Page M; Torrance J; Grady R
Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
[TBL] [Abstract][Full Text] [Related]
12. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
Borthwick TR; Benson GD; Schugar HJ
J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013
[TBL] [Abstract][Full Text] [Related]
13. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
[TBL] [Abstract][Full Text] [Related]
14. New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.
Di Bartolo N; Sargeson AM; Smith SV
Org Biomol Chem; 2006 Sep; 4(17):3350-7. PubMed ID: 17036125
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide.
Pujol AM; Cuillel M; Renaudet O; Lebrun C; Charbonnier P; Cassio D; Gateau C; Dumy P; Mintz E; Delangle P
J Am Chem Soc; 2011 Jan; 133(2):286-96. PubMed ID: 21155609
[TBL] [Abstract][Full Text] [Related]
16. The significance of copper chelators in clinical and experimental application.
Ding X; Xie H; Kang YJ
J Nutr Biochem; 2011 Apr; 22(4):301-10. PubMed ID: 21109416
[TBL] [Abstract][Full Text] [Related]
17. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
McQuaid A; Lamand M; Mason J
J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I synthesis and secretion are increased in Hep G2 cells depleted of copper by cupruretic tetramine.
Zhang JJ; Wang Y; Lei KY
J Nutr; 1995 Feb; 125(2):172-82. PubMed ID: 7861243
[TBL] [Abstract][Full Text] [Related]
20. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
